Wataru Minagawa is a prominent inventor based in Tochigi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antibacterial agents. With a total of 5 patents to his name, Minagawa's work focuses on improving the efficacy and stability of medicinal compounds.

Latest Patents

One of Minagawa's latest patents involves a compound known as 7-{(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid. This invention discloses a technique for enhancing the water solubility and storage stability of this compound, which exhibits strong antibacterial action, particularly against resistant bacteria. The patent details the creation of crystals of the hydrochloride salt and its hydrates, which demonstrate improved stability and solubility compared to the free compound. Additionally, Minagawa has developed a novel aqueous liquid formulation that suppresses chemical degradation of the compound, ensuring its effectiveness in medical applications.

Career Highlights

Minagawa is currently employed at Kyorin Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has been instrumental in advancing the development of new antibacterial agents that are safe and effective.

Collaborations

Throughout his career, Minagawa has collaborated with notable colleagues, including Ichiro Araya and Akinori Goto. These partnerships have contributed to the success of his research and the advancement of pharmaceutical technologies.

Conclusion

Wataru Minagawa's contributions to pharmaceutical chemistry highlight his dedication to improving medical treatments through innovative research. His patents reflect a commitment to addressing the challenges posed by resistant bacteria, making a significant impact in the field.

This text is generated by artificial intelligence and may not be accurate.